Paxmedica, Common Stock Stock Current Valuation
Valuation analysis of PaxMedica, Common Stock helps investors to measure PaxMedica, Common's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
PaxMedica, Common Stock Company Current Valuation Analysis
PaxMedica, Common's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current PaxMedica, Common Current Valuation | 388.33 K |
Most of PaxMedica, Common's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PaxMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, PaxMedica, Common Stock has a Current Valuation of 388.33 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
PaxMedica, Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PaxMedica, Common's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PaxMedica, Common could also be used in its relative valuation, which is a method of valuing PaxMedica, Common by comparing valuation metrics of similar companies.PaxMedica, Common is currently under evaluation in current valuation category among its peers.
PaxMedica, Fundamentals
| Return On Equity | -10.47 | ||||
| Return On Asset | -2.56 | ||||
| Current Valuation | 388.33 K | ||||
| Shares Outstanding | 7.47 M | ||||
| Shares Owned By Insiders | 8.14 % | ||||
| Shares Owned By Institutions | 1.60 % | ||||
| Number Of Shares Shorted | 637.72 K | ||||
| Price To Earning | 1.90 X | ||||
| Price To Book | 1.83 X | ||||
| EBITDA | (16.15 M) | ||||
| Net Income | (18.29 M) | ||||
| Cash And Equivalents | 9.06 K | ||||
| Total Debt | 173.54 K | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (10.77 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (11.00) X | ||||
| Target Price | 3.0 | ||||
| Market Capitalization | 5.14 M | ||||
| Total Asset | 5.68 M | ||||
| Retained Earnings | (52.03 M) | ||||
| Working Capital | 3.89 M | ||||
| Net Asset | 5.68 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |